Global Plasma Derived Therapies Market to Surpass US$58 Billion by 2028 with Robust Growth in Immunoglobulin and Albumin Segments
June 11, 2024 09:14 ET
|
Research and Markets
Dublin, June 11, 2024 (GLOBE NEWSWIRE) -- The "Plasma Derived Therapies Market (Immunoglobulin, Hemophilia, Specialty, and Albumin): Insights & Forecast (2024-2028)" report has been added to ...
Spherix Global Insights Expands Therapeutic Area Coverage into Hematology
June 10, 2024 04:00 ET
|
Spherix Global Insights
EXTON, PA, June 10, 2024 (GLOBE NEWSWIRE) -- Spherix Global Insights, a leading independent market intelligence and advisory firm that delivers commercial value to the global life sciences industry,...
Metagenomi Presents Data at Scientific Conferences and First Quarter 2024 Financial Results
May 14, 2024 16:05 ET
|
Metagenomi, Inc.
Late breaking presentation at World Federation of Hemophilia (WFH) World Congress on investigational development program in Hemophilia A; development candidate nomination anticipated in mid-year 2024;...
Aanastra Inc to Showcase its Peptide-RNA Therapeutics Technology in Multiple Presentations at the American Society for Gene and Cell Therapies (ASGCT) Annual Meeting 2024
May 02, 2024 06:30 ET
|
Aanastra Inc
Aanastra showcases its peptide-RNA therapeutics targeting p53, KRAS and BRCA-1 driven cancers, hemophilia A and PCSK9 for hypercholestrolemia at ASGCT
Comprehensive Analysis of Hematology Collaboration and Licensing Deals (2016-2024) Unveiled
May 02, 2024 05:25 ET
|
Research and Markets
Dublin, May 02, 2024 (GLOBE NEWSWIRE) -- The "Hematology Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.A thorough report on hematology...
Global Cell and Gene Therapies in Hemophilia A & B Analysis Report 2024: Market to Reach $2.2 Billion by 2029 - Major Players Are Expected To Intensify Competition
April 26, 2024 07:22 ET
|
Research and Markets
Dublin, April 26, 2024 (GLOBE NEWSWIRE) -- The "Cell and Gene Therapies in Hemophilia A & B" report has been added to ResearchAndMarkets.com's offering. The global hemophilia A and B CGT...
Metagenomi to Present at Upcoming Scientific Meetings
April 08, 2024 08:00 ET
|
Metagenomi, Inc.
- Oral Presentation at World Federation of Hemophilia (WFH) World Congress, April 23, 2024 - Two Posters at American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting, May 8...
Hemophilia Treatment Market Poised for Growth, Forecasts Indicate Strong Expansion by 2030
March 12, 2024 13:25 ET
|
Research and Markets
Dublin, March 12, 2024 (GLOBE NEWSWIRE) -- The "Hemophilia Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ResearchAndMarkets.com's offering. ...
Global Hemophilia Treatment Regimen and Therapy Research Report 2024: Market to Surpass $17.75 Billion by 2028, Driven by the Development of Novel Hemophilia Treatments
March 07, 2024 05:10 ET
|
Research and Markets
Dublin, March 07, 2024 (GLOBE NEWSWIRE) -- The "Global Hemophilia Market (By Treatment Regimen, Type & Therapy): Insights & Forecast with Potential Impact of COVID-19 (2024-2028)" report has...
Hemostasis Products Market revenue to hit USD 1.73 Billion by 2033, says Research Nester
February 06, 2024 07:30 ET
|
Research Nester
New York, Feb. 06, 2024 (GLOBE NEWSWIRE) -- The global hemostasis products market size is estimated to attain at ~5.1% CAGR from 2023 to 2033. The market is expected to garner a revenue of USD 1.73...